127378-46-5Relevant academic research and scientific papers
THIAZOLIDINEDIONE COMPOUNDS FOR TREATMENT OF DRUG RESISTANT ACUTE LYMPHOBLASTIC LEUKEMIA
-
Paragraph 0057, (2020/11/30)
Cell death may be induced in a cancer cell line, by treating the cancer cell line with a compound of formula (I), a compound of formula (II), pharmaceutically acceptable salts thereof, mixtures thereof, enantiomers thereof, or racemates thereof: wherein X
3,5-DI-TERTIARYBUTYL-4-HYDROXY-PHENYLMETHYLENE DERIVATIVES OF 2-SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND IMIDAZOLIDINONES AS ANTIINFLAMMATORY AGENTS
-
, (2008/06/13)
The novel 3,5-ditertiarybutyl-4-hydroxy-phenylmethylene derivative of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents having inhibiting activity for 5-lipoxygenase, cyclooxygenase, or both.
